Sugi Predict

Sugi Predict / Compounds / SCHEMBL3425481

SCHEMBL3425481

SCHEMBL3425481

C=CCC(CCCCCC(CC=C)(C(=O)c1ccc(NCCO)cc1)N(C)C)(C(=O)c1ccc(NCCO)cc1)N(C)C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ DRD4 P21917 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ HRH2 P25021 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ NTSR1 P30989 1/20 0.33
▸ HRH1 P35367 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ SCN1A P35498 1/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ SCN7A Q01118 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ SCN5A Q14524 1/20 0.33
▸ SCN9A Q15858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13310006 1.00 LMNA (0.33) LMNACYP1A2MAOACNR1DRD4
SCHEMBL6021947 0.99 LMNA (0.33) LMNACYP1A2MAOACNR1DRD4
SCHEMBL3425309 0.94 LMNA (0.33) LMNACYP1A2MAOACNR1DRD4
SCHEMBL3221660 0.88 LMNA (0.34) LMNACYP1A2MAOACNR1DRD4
SCHEMBL3432893 0.83 LMNA (0.33) LMNACYP1A2MAOACNR1DRD4
SCHEMBL3433517 0.77 LMNA (0.39) LMNACYP1A2MAOACNR1DRD4
SCHEMBL3424355 0.74 RORC (0.40) LMNAACHESCN1ASCN2ASIGMAR1
SCHEMBL3431893 0.73 POLB (0.33) KDM4EMLYCDPOLBPRSS1F2
SCHEMBL8898410 0.73 CYP1A2 (0.41) LMNACYP1A2RAB9AMAPT
SCHEMBL13309995 0.73 POLB (0.39) LMNACYP1A2MAOACNR1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304810-A1 INK JET INK, IMAGE RECORDING METHOD, AND MANUFACTURING METHOD OF LAMINATE FUJIFILM CORPORATION (JP) 2025-10-02 — — US disclosed
EP-4624539-A1 INK JET INK, IMAGE RECORDING METHOD, AND MANUFACTURING METHOD OF LAMINATE FUJIFILM Corporation (JP) 2025-10-01 — — EP disclosed
EP-2664629-B1 Functionalised photoinitiators BASF SE (DE) 2014-11-12 — — EP disclosed
EP-2664629-A1 Functionalised photoinitiators Ciba Holding Inc. (CH) 2013-11-20 — — EP disclosed
US-7732504-B2 Functionalized photoinitiators CIBA SPECIALTY CHEMICALS CORPORATION (US) 2010-06-08 — — US disclosed
US-20080021126-A1 Functionalized Photoinitiators IGM GROUP B.V. (NL) 2008-01-24 — — US disclosed
EP-1711862-A2 FUNCTIONALIZED PHOTOINITIATORS CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) 2006-10-18 — — EP disclosed
WO-2005076074-A2 FUNCTIONALIZED PHOTOINITIATORS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021126-A1 Functionalized Photoinitiators PPOX, TYR, CYP1A1 LMNA 2359/4885CYP1A2 12/4885MAOA 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.